Information  X 
Enter a valid email address

Virotec Intl Ld (VTI)

  Print      Mail a friend

Friday 29 April, 2005

Virotec Intl Ld

3rd Quarter Cash Flow Report

Virotec International Ld
29 April 2005

This document is lodged in accordance with ASX listing rule 4.7B

                                Quarterly report
                             for entities admitted
                          on the basis of commitments


Name of entity
Virotec International Ltd

ABN                          Quarter ended ('current quarter')
-------------------          ------------------
81 004 801 398               31 March 2005
-------------------          ------------------

Consolidated statement of cash flows

                                                     ------------   ------------
Cash flows related to operating activities             Current        Year to
                                                       quarter        date
                                                       $A'000         (9 Months)
                                                                      $A'000
                                                       ------------ ------------
1.1   Receipts from customers                                 482        1,899
1.2   Payments for (a) staff costs                           (793)      (2,229)
      (b) advertising and marketing                           (27)         (79)
      (c) research and development                           (319)        (943)
      (d) leased assets                                         -            -
      (e) other working capital                            (1,010)      (3,643)
1.3   Dividends received                                        -            -
1.4   Interest and other items of a similar nature             73          225
      received
1.5   Interest and other costs of finance paid                 (1)          (1)
1.6   Income taxes paid                                         -            -
1.7   Other (mining interests costs)                          (23)        (106)
                                                       ------------ ------------
1.8   Net operating cash flows                             (1,618)      (4,877)
                                                       ------------ ------------
Cash flows related to investing activities

1.9   Payment for acquisition of:                              
      -businesses (item 5)                                     -             -
      -equity investments                                      -           (49)
      -intellectual property                                   -             -
      -physical non-current assets                          (240)         (865)   
      -other non-current assets                                -             -
1.10  Proceeds from disposal of:                             
      -businesses (item 5)                                   350         1,592  
      -equity investments                                      -             -
      -intellectual property                                   -             -
      -physical non-current assets                            18            18 
      -other non-current assets                                -             -
1.11  Loans to other entities                                  -             -
1.12  Loans repaid by other entities                           -         1,242
1.13  Other (Refund of security deposits)                      -            60
                                                      ------------  ------------
       Net investing cash flows                              128         1,998
                                                      ------------  ------------
1.14   Total operating and investing cash flows           (1,490)       (2,879)
                                                      ------------  ------------
Cash flows related to financing activities

1.15   Proceeds from issues of shares, options,              238           308
       etc.
1.16   Proceeds from sale of forfeited shares                  -             -
1.17   Proceeds from borrowings                                -            31
1.18   Repayment of borrowings                                (5)           (5)
1.19   Dividends paid                                          -             -
1.20   Other (share issue costs)                               -             -
                                                      ------------  ------------
       Net financing cash flows                              233           334
------ ----------------------                         ------------  ------------
       Net increase (decrease) in cash held               (1,257)       (2,545)

1.21   Cash at beginning of quarter/year to date           6,379         7,667
1.22   Exchange rate adjustments to item 1.20                  -             -
                                                      ------------  ------------
1.23   Cash at end of quarter                              5,122         5,122
------ ----------------------                         ------------  ------------



Payments to directors of the entity and associates of the directors

Payments to related entities of the entity and associates of the related
entities

                                                                 -------------
                                                                    Current
                                                                    quarter
                                                                    $A'000
                                                                 -------------
                                                                  -------------
1.24   Aggregate amount of payments to the parties included in             321
       item 1.2                                                   -------------
1.25   Aggregate amount of loans to the parties included in item 1.11       -
                                                                  -------------
       --------------------------------
1.26   Explanation necessary for an understanding of the transactions
       -------------------------------------------
       Director fees:    $59,366
       Consultancy fees $261,980
       -------------------------------------------

Non-cash financing and investing activities

2.1   Details of financing and investing transactions which have had a material
      effect on consolidated assets and liabilities but did not involve cash
      flows
      --------------------------------------------
      Nil
      --------------------------------------------

2.2   Details of outlays made by other entities to establish or increase their
      share in businesses in which the reporting entity has an interest
      --------------------------------------------
      Nil
      --------------------------------------------

Financing facilities available

Add notes as necessary for an understanding of the position. (See AASB 1026
paragraph 12.2).
                                            -------------         -------------
                                            Amount available       Amount used
                                            $A'000                 $A'000
                                            -------------         -------------
3.1   Loan facilities                                  26                 26
                                            -------------         -------------
3.2   Credit standby arrangements                      -                   -
----- -----------------------               -------------         -------------

Reconciliation of cash

-------------------------                             ------------ -------------
Reconciliation of cash at the end of the quarter (as  Current      Previous
shown in the consolidated statement of cash flows) to quarter      quarter
the related items in the accounts is as follows.
                                                      $A'000       $A'000
                            ------------------------- ------------ -------------
                                                                   
4.1   Cash on hand and at bank                               450         2,574
                                                      ------------ -------------
4.2   Deposits at call                                     4,672         3,805
                                                      ------------ -------------
4.3   Bank overdraft                                           -             -
                                                      ------------ -------------
4.4   Other (provide details)                                  -             -
----- ----------------------                          ------------ -------------
      Total: cash at end of quarter (item 1.22)            5,122         6,379
----- ----------------------                          ------------ -------------

Acquisitions and disposals of business entities

                             -----------------    ------------------
                             Acquisitions         Disposals
                             (Item 1.9(a))        (Item 1.10(a))
                             -----------------    ------------------
                                                  ------------------
5.1   Name of entity                       -      ViroLab Analytical Services
                             -----------------    Business
                                                  ------------------
5.2   Place of incorporation               -      Not Applicable - Business
      or registration        -----------------    disposed of only on 10 January
                                                  2005
                                                  ------------------
5.3   Consideration for                    -       $350,000
      acquisition or
      disposal               -----------------    ------------------
5.4   Total net assets                     -       $300,001
                             -----------------    ------------------
5.5   Nature of business                   -      Analytical laboratory services
                             -----------------    ------------------

Compliance statement

1 This statement has been prepared under accounting policies which comply with
accounting standards as defined in the Corporations Act (except to the extent
that information is not required because of note 2) or other standards
acceptable to ASX.

2 This statement does give a true and fair view of the matters disclosed.


Sign here: ............................................ Date: 29 April 2005
           (Company Secretary)

Print name: Angus Craig

Notes

1. The quarterly report provides a basis for informing the market how the
entity's activities have been financed for the past quarter and the effect on
its cash position. An entity wanting to disclose additional information is
encouraged to do so, in a note or notes attached to this report.
2. The definitions in, and provisions of, AASB 1026: Statement of Cash Flows
apply to this report except for the paragraphs of the Standard set out below.
• 6.2 - reconciliation of cash flows arising from operating activities to
        operating profit or loss
• 9.2 - itemised disclosure relating to acquisitions
• 9.4 - itemised disclosure relating to disposals
• 12.1(a) - policy for classification of cash items
• 12.3 - disclosure of restrictions on use of cash
• 13.1 - comparative information
3. Accounting Standards. ASX will accept, for example, the use of International
Accounting Standards for foreign entities. If the standards used do not address
a topic, the Australian standard on that topic (if any) must be complied with.


                            Virotec International Ltd
                                ABN 81004801398
                                   PO BOX 188
                            Sanctuary Cove QLD 4212
                                    Australia
                                www.virotec.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange